Objective We investigated the effect of IL-1b on the development of intestinal epithelial stem cells. Materials and methods Normal intestinal epithelial cell line IEC-18 cells were cultured in the presence or absence of 200 pM of IL-1b in serum-free medium (SFM) for various time periods. The effects of IL-1b on intestinal stem cell self-renewal and IEC-18 cell proliferation were evaluated by a colony formation assay, MTT assay, and a focus formation assay. The expression of stemness genes including Bmi-1, Lgr-5, c-myc, Nanog, and b-catenin in IEC-18 cells were measured by quantitative PCR and western blot analysis. Results IEC-18 cells grew as a monolayer in SFM in the absence of IL-1b. Cellular spheres were formed when IEC-18 cells were grown in SFM in the presence of IL-1b. IL-1b induced the development of large colonies in the soft-agar as well as the formation of foci when IEC-18 cells were cultured in type-I collagen-coated plates. The expression of Bmi-1, Lgr-5, c-myc, Nanog, and b-catenin were significantly increased in IEC-18 cells treated with IL-1b. Conclusion Our studies provide direct evidence the IL-1b may play an important role in the self-renewal of intestinal epithelial stem cells and the development of cancer stem cells.
Introduction
The renewal of intestinal epithelium is a tightly controlled process and is essential for maintaining the integrity of the mucosa, repairing mucosal injury, and replenishing the specialized cells of the epithelium. Alterations in epithelial renewal are closely involved in transformation of the epithelium to benign and malignant tumors. It has been suggested that homeostasis of the intestinal epithelium is maintained by an intestinal stem cell (ISC) compartment that resides at the bottom of the crypt of the small and large intestine [1] .
The location and behavior of ISCs within the base of intestinal crypt have been characterized by numerous investigators using various animal models [2, 3] . Current literature supports two different hypothesis of ISCs: one hypothesis suggests that ISCs are located above the Paneth cells (?4 position), expressing Bmi-1, and normally maintained in a quiescent state through direct interaction with and signals from the niche [2] . The other hypothesis implies that ISCs are crypt base columnar (CBC) cells that are located between the Paneth cells, continuously activated by signals generated from stromal cells at the crypt base, and responsible for most of the regenerative capacity of the intestine under homeostatic conditions [2] . Although significant progress has been made in the last few decades in ISC research, the identity of ISCs is still being debated due to the tremendous technical difficulty in isolating and genetically marking ISCs to definitively demonstrate their stemness. Thus far, the molecular mechanisms regulating maintenance of these ISCs and regeneration of intestinal epithelia are not well understood.
In addition to renewal of intestinal epithelium, ISCs have also been indicated as the cells of origin of intestinal cancers [4] . Dysregulation of stem cell proliferation has been linked to formation and progression of tumors [5] . Recent studies have shown that inflammation can promote tumorigenesis by inducing hyper-proliferation of gastrointestinal stem cells [6] [7] [8] [9] [10] . However, the identities of inflammatory factors responsible for the induction of supernumerary ISCs are still unclear.
Human patients with inflammatory bowel disease (IBD), including both ulcerative colitis and Crohn's disease, have a two-to-three fold greater lifetime risk of developing colorectal cancer compared to the general population [11] . IL-1b, a pleiotropic pro-inflammatory cytokine, is significantly up-regulated in IBD patients [12] [13] [14] , and blocking IL-1b can result in attenuated disease [15] . Furthermore, up-regulation of IL-1b has been closely associated with gastrointestinal tumor initiation and progression [16, 17] . We have previously shown that mice with a higher level of baseline IL-1b in the intestine are more susceptible to dextran sulfate sodium (DSS)-induced colitis [18] . Our recent discovery that IL-1b promotes the development of brain cancer stem cells (CSCs) from differentiated cancer cells [19] prompted us to determine whether IL-1b can induce the development of ISCs and CSCs from normal intestinal epithelial cell cultures. Here, we report that IL-1b can promote the development of ISCs from normal intestinal epithelial cell culture and IL-1b-induced ISC expansion leads to the loss of cell contact inhibition that is often demonstrated by transformed cells.
Materials and methods

Cell line and culture conditions
A rat normal intestinal epithelial cell line, IEC-18, was a kind gift from Dr. Sherry Fleming (Kansas State University, Manhattan, KS, USA). Cells were cultured in serumfree medium (SFM) which consisted of neurobasal-A medium supplemented with B27, GlutaMAX-I supplement, 1 % penicillin-streptomycin (Invitrogen, Carlsbad, CA, USA), 50 ng/ml heparin (Sigma-Aldrich, Saint Louis, MO, USA), 20 ng/ml of EGF, and 20 ng/ml bFGF (R&D systems, Minneapolis, MN, USA). To determine the effects of IL-1b on cell growth, 200 pM IL-1b (R&D Systems) was added every other day to SFM.
Self-renewal assay and cell proliferation assay IEC-18 cells at a clonal density of 1 cell/ll in SFM were seeded at 100 ll/well in 96-well plates and treated with or without 200 pM IL-1b for 7 days. IL-1b was added every other day. The total number of cells in each well was counted under a microscope after trypan blue staining. Cell proliferation was measured using the cell proliferation kit I (MTT, Roche Applied Science, Indianapolis, IN, USA) as described by the manufacturer.
Soft agar assay: colony formation assay
The soft agar assay was performed in 6-well plates containing two layers of Sea Plague Agar (Invitrogen). The bottom layer consisted of 0.8 % agar in 1 ml of SFM. Single IEC-18 cells (1 9 10 5 /well) were placed in the top layer containing 0.4 % agar in SFM. The top layer agar was covered with 0.5 ml of SFM with or without 200 pM IL-1b. The top medium was changed every 4 days and fresh IL-1b was added to the top medium every other day. Cells were cultured for 40 days. Colonies were photographed under a microscope and measured using the ImageJ program (http://imagej.nih.gov). Colonies with diameters larger than 30 lm were counted. RNA extraction and quantitative RT-PCR Total RNAs were extracted using TRI reagent (SigmaAldrich), followed by digestion with a DNase kit (Applied Biosystems, Carlsbad, CA, USA) to remove DNA residues. Reverse transcription was carried out using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA, USA) and quantitative real-time PCR was performed using SsoFast Eva Green Supermix kit (Bio-Rad).
Western blot analysis IEC-18 cells were cultured in SFM in the absence or presence of IL-1b for 7 days. Cells were then washed with cold PBS, lysed in RIPA buffer [25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1 % NP-40, 1 % sodium deoxycholate, 0.1 % SDS] and pelleted by centrifugation. Protein concentrations were determined using a NanoDrop instrument (Thermo Fisher Scientific). Cell lysates (30 lg protein for each sample) were incubated for 5 min at 100°C in 29 loading buffer, separated by electrophoresis in 10 % polyacrylamide gels, and transferred to PVDF membranes (Millipore, Bedford, MA, USA). Membranes were blocked with 5 % milk in PBS and then incubated with a primary antibody anti-Bmi-1 clone F6 (1:1,000 dilution, Millipore), anti-b-catenin (1:1,000, Cell Signaling, Boston, MA, USA), or anti-b-actin (1:1,000 dilution, Sigma), and a secondary antibody HRP-conjugated goat anti-mouse IgG-HRP (1:1,000 dilution, Millipore) or antirabbit IgG HRP-linked antibody (1:1,000 dilution, Cell Signaling), respectively. Detection was performed using HyGLO substrate (Denville Scientific, Metuchen, NJ, USA) and images were taken using the AlphaEaseFC imaging system (Cell Biosciences, Santa Clara, CA, USA).
Statistical analysis
Student's t test was used to determine statistical significance for all analyzed data. A two-sided p \ 0.05 was considered significant.
Results
IL-1b induces sphere formation and colony formation of IEC-18 cells in serum-free medium
Consistent with previous reports by others [20, 21] , we also found that rat intestinal epithelial cell line IEC-18 cells exhibit a number of characteristic features of normal intestinal epithelia cells in culture: strong cell-cell contact or density inhibition of growth, lack of growth in soft agar, and a low plating efficiency when seeded at a low density. To determine whether there are any active stem cells in IEC-18 cells, we cultured these cells in SFM supplemented with bFGF and EGF (SFM). SFM is routinely used to maintain stem cells at an undifferentiated stem cell state, while bFGF and EGF induce proliferation of normal and neoplastic epithelial stem cells as sphere-like cellular aggregates [22] [23] [24] . We found that IEC-18 cells proliferated as a monolayer culture in SFM, suggesting that normal IEC-18 cells do not have active stem cells. However, addition of IL-1b to SFM induced some IEC-18 cells to proliferate as spheres (Fig. 1) . Meanwhile, we compared the proliferation rates of IEC-18 monolayer cells and IL1b-induced sphere cells using a MTT assay and trypan-blue staining method. As shown in Fig. 1b , c, IL-1b-induced sphere cells grew significantly (p \ 0.05) slower than the untreated monolayer cells.
To verify that IL-1b-induced spheres are not the result of cell aggregation, we performed soft agar colony formation assays in serum-free conditions. Under these conditions, cells are separated by semisolid culture medium to prevent aggregation. More importantly, this assay can distinguish between normal differentiated cells and stem cells. Differentiated cells undergo anoikis in the absence of anchorage to a substratum, while stem cells can survive in anchorage-independent conditions and form colonies [24] . To perform the colony formation assay, IEC-18 cells were placed in soft agar in SFM with or without IL-1b and cultured for 40 days. In the absence of IL-1b, most IEC-18 cells in the soft agar underwent anoikis and no colonies were formed. However, some colonies were generated among the IEC-18 cells treated with IL-1b (Fig. 1d, e) . The efficiency of colony-forming cells was around 0.03 % (Fig. 1f) , indicating that IL-1b stimulates a rare sub-population of IEC-18 cells to self-renew, proliferate, and form colonies.
In addition, we also evaluated whether IL-1b-induced sphere IEC-18 cells still maintained self-renewal ability without IL-1b. IL-1b-induced spheres were dissociated and cultured in SFM without IL-1b for 7 days. The cytokinewithdrawn cells proliferated as monolayer cells and exhibited similar morphology as control cells without cytokine treatment (data not shown). This result suggests that constant presence of IL-1b in the medium is required for the activation and maintenance of ISC self-renewal.
IL-1b induces loss of contact inhibition of IEC-18 cells in SFM
Contact inhibition is the natural process of arresting cell growth when normal cells contact nearby cells. However, malignant cells lose this property and continue to divide, forming a mass of cells as a tumor. In culture, normal cells grow in a single layer on the substratum but malignant cells continue to grow and form excess layers of cells, called foci. Therefore, we examined whether IL-1b-induced ISCs possess properties of cancer cells by doing focus assays. To determine whether IL-1b can cause IEC-18 cells to grow without contact inhibition, plates were coated with collagen to allow cells to grow as adherent cells in SFM with or without IL-1b (Fig. 2a) . The effects of IL-1b on IEC-18 cell proliferation were evaluated before cells reached confluency using a MTT assay. As shown in Fig. 2b , IL-1b treated cells proliferated significantly (p \ 0.05) slower than control cells. When cells reached confluency, control cells stopped growing and formed a monolayer culture. However, IL-1b-treated cells continued to grow and formed excess layers of cells (foci).
To confirm focus formation, the above cell cultures were stained with Giemsa on day 14. In this assay, monolayer cells were in grey while foci were in purple (Fig. 2c) , indicating piling of cells in foci. The number of purple foci in each well was counted under a microscope. As shown in Fig. 2d , foci were formed only when IEC-18 cells were treated with IL-1b. To further verify the formation of foci, we also compared the total number of IEC-18 cells in each well treated with or without IL-1b for 14 days after they reached confluency. As shown in Fig. 2e , there were significantly more IEC-18 cells in the wells with IL-1b than that in the wells without IL-1b. This result is consistent with the microscopic observation that multilayer of cells (focus formation) present in IL-1b-treated wells.
IL-1b induces expression of stem cell markers in IEC-18 cells in SFM
To determine the molecular mechanisms of IL-1b-induced colony and focus formation, we compared the expression of several stemness genes in IEC-18 cells treated with or without IL-1b in SFM. As shown in Fig. 3a , the expression of stem cell markers Bmi-1, Lgr5, c-myc, b-catenin and Nanog were significantly (p \ 0.01) increased in IL-1b-treated cells cultured in SFM, compared to that in control cells cultured in the same condition. IL-1b-induced protein expression of Bmi-1 and b-catenin was further confirmed by western blot analysis (Fig. 3b) . These results suggest that IL-1b induces stemness gene expression, leading to colony and focus formation in SFM.
Discussion
The homeostasis of intestinal epithelium renewal is essential for maintaining the structural and functional integrity of intestinal mucosa. Dysregulation of the selfrenewal of intestinal epithelium may lead to the development of gastrointestinal cancers. Therefore, it is not surprising that the host has developed a tightly controlled system to maintain efficient interaction between ISCs, their progenies, and the microenvironment. Although a significant amount of literature supports the notion that ISCs can be the cells of origin for intestinal cancers [4] and inflammation may play an important role in ISC-mediated tumorigenesis [6] [7] [8] [9] [10] , how ISC renewal and intestinal CSCs are regulated by inflammatory cytokines remains obscure. Here, we present data that IL-1b can promote selfrenewal and proliferation of intestinal epithelial stem cells and regulate the development of intestinal CSCs.
IEC-18 cells are normal small intestinal crypt cells that were established in vitro from the ileum of outbred germfree Crl:CD(SD)GN rats [20] . Because IEC-18 cells in SFM demonstrate a monolayer culture and lack of growth in soft agar, we speculate that normal IEC-18 cells do not contain ISCs or the ISCs are inactive. Interestingly, addition of IL-1b to the cell culture caused monolayer cells to form spheres expressing up-regulated ''stemness'' genes including Lgr-5, Bmi-1, cMyc-1, b-catenin, and Nanog. The sphere cells proliferate at a slower rate compared with control monolayer IEC-18 cell, and this is consistent with the observation that stem cells grow slower than differentiated cells [25] . Because only a small portion (0.03 %) of IEC-18 cells possess stem cell properties, it is likely that normal IEC-18 cell cultures contain a rare population of quiescent ISCs that can be reactivated by IL-1b. However, our studies cannot rule out the possibility that these colonies and spheres are the de novo induction of stem cells from normal progenitor cells by IL-1b. Nonetheless, it is reasonable to conclude that IL-1b can support the development of intestinal epithelial stem cells.
Bmi-1, a transcriptional repressor belonging to the polycomb group protein family, is a well-recognized molecular marker for ISCs. The leucine-rich, repeat-containing G protein-coupled receptor (Lgr-5), also called GPR49, is another marker of stem cells in adult intestinal epithelium [3] . Although the exact function of Lgr-5 is unknown, it represents a different group of stem cells in the intestine because Lgr-5 is mainly expressed in the CBC cells which are located between the Paneth cells, while Bmi-1 is expressed in ?4 cells which are located above the Paneth cells [2] . Thus, these two markers label two different states of ISCs. Lgr-5-expressing cells are actively proliferating stem cells responsible for the daily maintenance of the intestine epithelium, while Bmi-1-expressing cells are normally maintained in a quiescent state [2] . Recent studies on these two stem cell populations indicate that Bmi-1-expressing cells are up-stream of the rapidly dividing Lgr-5
? cells and replenish the pool of active stem cells under normal circumstances [26] . Moreover, Bmi-1-expressing cells can also directly give rise to all intestinal ? cells in Lgr-5-deficient mice, indicating that Lgr-5 expression is dispensable for the homeostasis of intestinal epithelium [26] . However, ablation of Bmi-1-expressing cells can lead to depletion of whole crypt units [27] . Thus, Bmi-1-expressing cells appear to be more critical than ? cells for crypt maintenance. Our studies have shown that the expression of Bmi-1 and Lgr-5 is significantly enhanced in IL-1b-induced IEC-18 sphere cells. The finding suggests that there were two subsets of ISCs present in the original IEC-18 cell line when they were isolated from rat intestinal crypt, and IL-1b promotes the expansion of both stem cell populations. Further studies are needed in order to determine whether Lgr-5
? IEC-18 cells are derived from the Bmi-1-expressing IEC-18 cells.
It has been suggested that IL-1b alone can induce inflammation and gastric cancer through recruitment and activation of myeloid-derived suppressor cells (MDSCs) [16] . MDSCs serve as a source for IL-6 production and IL-6-induced activation of STAT3 in epithelial cells can lead to tumor initiation [16, 28, 29] . In a difference from the previous report, we have shown that IL-1b could act directly on IEC-18 cells to promote the expression of both Bmi-1 and Lgr-5 and a functional phenotype of loss of contact inhibition of growth and anchor-independent colony formation, typical characteristics of cancer cells. Results from our studies are consistent with the notion that Bmi-1 and Lgr-5 not only are hall markers of ISCs, but also are strongly expressed in gastrointestinal neoplasias [2, 3] . Thus, our data suggest that IL-1b could directly target epithelial cells to induce ISC-mediated tumorigenesis.
Canonical Wnt/b-catenin pathway is a key signaling mechanism for intestinal proliferation, maintenance of ISCs, and development of colorectal cancer cells. Wnt signaling regulates b-catenin's stability, accumulation in the cytoplasm, and translocation into the nucleus [30] . Both ISC markers Bmi-1 and Lgr-5 have been shown to be the downstream targets of Wnt/b-catenin signaling [31, 32] . Because IL-1b can significantly enhance the expression of b-catenin, Bmi-1 and Lgr-5 in IEC-18 cells (Fig. 3) , it is possible that the effect of IL-1b on ISC self-renewal and cancer stem cell development is mediated by the Wnt/ b-catenin pathway. This notion is consistent with the report that IL-1b alone is sufficient to activate Wnt signaling and is required for increased Wnt signaling in colon cancer cells [33] . However, further studies are required to determine the molecular mechanism of IL-1b-mediated Wnt/ b-catenin signaling in ISCs and CSCs.
Numerous studies have demonstrated that the development and maintenance of ISCs and cancer cells are regulated by inflammation in the intestinal crypt. Therefore, it is reasonable to speculate that key inflammatory cytokines such as IL-1b may be involved in the microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Under physiological conditions, it is likely that inflammation-responsive ISCs would become quiescent again after tissue wound is healed and inflammation is resolved. However, persistently over-expression of IL-1b in chronic inflammation could induce over-proliferation of ISCs. Our studies provide the first evidence that IL-1b can directly act on intestinal epithelial cells to activate ISC self-renewal, which in turn contributes to inflammation-mediated epithelial repair and/or tumorigenesis depending on the intensity and duration of intestinal inflammation.
